Intuitive medical device firm and the innovation leader in minimally invasive care has secured the US FDA endorsement for da Vinci 5, the organization's cutting-edge multiport robotic system. “We are pleased to receive...
Pharmaceutical and healthcare firm Sanofi announced an exclusive distribution with Cipla for their Central Nervous System (CNS) product line in India. Because of this partnership, Cipla will deal with disseminating Sanofi India's six CNS brands...
Astellas Pharma Inc., based in Tokyo, reported the other day Japan's Ministry of Health, Labour and Welfare approved VYLOYâ„¢ (zolbetuximab), an anti-claudin 18.2 (CLDN18.2) monoclonal neutralizer for patients with CLDN18.2 positive, unresectable...
The department of pharmaceuticals (DoP) has framed with another arrangement of rigid marketing code for the pharma organizations. Uniform Code for Drug Showcasing Practices (UCPMP) 2024 is the new code and is “mandatory†and would supplant the...
The Indian Institute of Technology Guwahati has achieved a significant milestone by successfully transferring a groundbreaking vaccine technology to BioMed Pvt. Ltd., a renowned manufacturer specializing in high-quality vaccines.This innovative ...
Verge Genomics, a leading biotechnology firm, has declared a partnership with Ferrer to co-foster VRG50635, Verge’s lead candidate, for the treatment of irregular and familial types of amyotrophic lateral sclerosis (ALS) in Europe, Central and...
Baby Memorial Hospital, Kozhikode, a venerable institution with over three decades of unwavering commitment to accessible and quality healthcare, announces the launch of the ‘ContinuousConnectedCare@BMH’ initiative. In a pioneering move, all ward...
Wipro GE Healthcare services declared funding of more than $1 billion (Rs 8000 crore) in manufacturing results and nearby research and development (R&D) for the next five years. This essential speculation supports Wipro GE Healthcare’s local...
AstraZeneca's Ultomiris (ravulizumab-cwvz) has been sanctioned in the United States as the initial and long-acting C5 supplement inhibitor for the treatment of grown-up patients with anti- aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis...
The pharmaceutical firm Novo Nordisk has consented to purchase Cardior Pharmaceuticals for €1bn (£856bn) as it ventures into the cardiovascular pipeline. The Danish pharmaceutical drugmaker is building an arrangement of treatments in areas...
, CDSCO.jpg)
